Reduced oxygen extraction fraction in deep cerebral veins associated with cognitive impairment in multiple sclerosis.
Hasan SawanChenyang LiSagar BuchEvanthia BernitsasE Mark HaackeYulin GeYongsheng ChenPublished in: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2024)
Studying the relationship between cerebral oxygen utilization and cognitive impairment is essential to understanding neuronal functional changes in the disease progression of multiple sclerosis (MS). This study explores the potential of using venous susceptibility in internal cerebral veins (ICVs) as an imaging biomarker for cognitive impairment in relapsing-remitting MS (RRMS) patients. Quantitative susceptibility mapping derived from fully flow-compensated MRI phase data was employed to directly measure venous blood oxygen saturation levels (S v O 2 ) in the ICVs. Results revealed a significant reduction in the susceptibility of ICVs (212.4 ± 30.8 ppb vs 239.4 ± 25.9 ppb) and a significant increase of S v O 2 (74.5 ± 1.89% vs 72.4 ± 2.23%) in patients with RRMS compared with age- and sex-matched healthy controls. Both the susceptibility of ICVs ( r = 0.508, p = 0.031) and the S v O 2 ( r = -0.498, p = 0.036) exhibited a moderate correlation with cognitive decline in these patients assessed by the Paced Auditory Serial Addition Test, while no significant correlation was observed with clinical disability measured by the Expanded Disability Status Scale. The findings suggest that venous susceptibility in ICVs has the potential to serve as a specific indicator of oxygen metabolism and cognitive function in RRMS. .
Keyphrases
- multiple sclerosis
- cognitive impairment
- cognitive decline
- end stage renal disease
- white matter
- ejection fraction
- high resolution
- chronic kidney disease
- magnetic resonance imaging
- subarachnoid hemorrhage
- mass spectrometry
- peritoneal dialysis
- ms ms
- prognostic factors
- magnetic resonance
- mild cognitive impairment
- climate change
- patient reported outcomes
- single cell
- inferior vena cava
- contrast enhanced
- cerebral ischemia
- rheumatoid arthritis
- working memory
- blood brain barrier
- systemic lupus erythematosus
- machine learning
- risk assessment
- human health
- cerebral blood flow